Metro Healthcare Indonesia Tbk. vs Pudjiadi & Sons Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp426 (market cap 14.16T, 104.9K 24h volume), while Pudjiadi & Sons Tbk. trades at Rp498 (market cap 387.74B, 200 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 36.5× Pudjiadi & Sons Tbk.'s market cap, and Metro Healthcare Indonesia Tbk. is more actively traded (104.9K versus 200). Which is the better fit depends on your goals.
| CARE | PNSE | |
|---|---|---|
Market Cap | 14.16T | 387.74B |
Volume | 104.9K | 200 |
Lot | 1.05K | 2 |
Turnover | 44.39M | 99K |
Average Price | 423.17 | 495 |
Value | 44.39M | 99K |
Indicative Equilibrium Price | — | 492 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Pudjiadi and Sons Tbk was established based on Notarial Deed No. 34 dated December 17, 1970 of Ridwan Suselo, s.h., notaris in Jakarta. Hotel business with all the facilities and infrastructures, such as , accommodation, office, shopping mall, apartment, recreation place and entertainment in the location of hotel. The Company is the owner of Jayakarta Hotel, a four star hotel.
Read more on PNSE →